SPEND SMART. SUCCEED SOONER.
SciLucent provides regulatory, scientific, and management consulting services to healthcare product companies that manufacture and/or market pharmaceuticals, biopharmaceuticals, medical devices, combination products, and dietary supplement ingredients.
Since 1998 we have provided our clients with innovative strategies and exceptional quality work products intended to enhance product development, approval, and marketing presence.
Manufacturing & Development
Ensuring the consistent manufacture of a high-quality product appropriate to the stage of development
Quality & Compliance
Providing comprehensive oversight of GxP activities to support the development of regulated healthcare products
Nonclinical Safety & Development
Designing and executing nonclinical program strategies to successfully enable clinical trials and marketing applications
Focusing clinical studies to obtain quality data for regulatory agency review
Developing a sound strategy and persuasive regulatory documents to more quickly advance a product to market
Producing high-quality, cost effective submissions accepted for regulatory review
SciLucent Responds to COVID-19 Pandemic
SciLucent’s management continues to monitor the rapidly evolving coronavirus (COVID-19) pandemic and has taken several steps to maintain the health and safety of its employees. We are following all state and federal restrictions regarding travel, social distancing, and isolation. As scientific and regulatory professionals, we are very much aware of the importance of continuing efforts to get promising treatments into the hands of those in need. As such, SciLucent continues to provide its consulting services with no change in the level of service. We are actively engaging and doing our part in the global efforts to develop preventative and treatment options for patients with COVID-19.
What can you expect from SciLucent?